1. Home
  2. FATE vs TROO Comparison

FATE vs TROO Comparison

Compare FATE & TROO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • TROO
  • Stock Information
  • Founded
  • FATE 2007
  • TROO 2005
  • Country
  • FATE United States
  • TROO Hong Kong
  • Employees
  • FATE N/A
  • TROO N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • TROO Radio And Television Broadcasting And Communications Equipment
  • Sector
  • FATE Health Care
  • TROO Technology
  • Exchange
  • FATE Nasdaq
  • TROO Nasdaq
  • Market Cap
  • FATE 116.5M
  • TROO 103.8M
  • IPO Year
  • FATE 2013
  • TROO N/A
  • Fundamental
  • Price
  • FATE $0.96
  • TROO $1.24
  • Analyst Decision
  • FATE Hold
  • TROO
  • Analyst Count
  • FATE 6
  • TROO 0
  • Target Price
  • FATE $3.30
  • TROO N/A
  • AVG Volume (30 Days)
  • FATE 1.4M
  • TROO 178.2K
  • Earning Date
  • FATE 11-11-2025
  • TROO 04-30-2025
  • Dividend Yield
  • FATE N/A
  • TROO N/A
  • EPS Growth
  • FATE N/A
  • TROO N/A
  • EPS
  • FATE N/A
  • TROO N/A
  • Revenue
  • FATE $8,470,000.00
  • TROO $10,073,000.00
  • Revenue This Year
  • FATE N/A
  • TROO N/A
  • Revenue Next Year
  • FATE N/A
  • TROO N/A
  • P/E Ratio
  • FATE N/A
  • TROO N/A
  • Revenue Growth
  • FATE N/A
  • TROO 182.24
  • 52 Week Low
  • FATE $0.66
  • TROO $0.49
  • 52 Week High
  • FATE $4.20
  • TROO $4.10
  • Technical
  • Relative Strength Index (RSI)
  • FATE 40.81
  • TROO 66.38
  • Support Level
  • FATE $0.93
  • TROO $0.98
  • Resistance Level
  • FATE $1.08
  • TROO $1.09
  • Average True Range (ATR)
  • FATE 0.07
  • TROO 0.11
  • MACD
  • FATE -0.01
  • TROO 0.01
  • Stochastic Oscillator
  • FATE 13.79
  • TROO 82.89

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About TROO TROOPS Inc.

TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.

Share on Social Networks: